Cleerly vs Hyperfine Swoop

Hyperfine's FY2025 10-K describes Swoop as an owned system, followed by an annual software, service and support agreement on 36- or 60-month terms after a one-year warranty. No dollar figure is public. An older Scientific Reports paper estimated about $50,000 a system, and the 10-K puts conventional MRI at about $1.2 million on average.

Swoop suits an ICU or a hospital without a shielded MR suite that needs bedside brain imaging at 0.064T and can live with lower resolution and no contrast-enhanced T1. CPT Category I code 75577, in force since January 2026, and a PowerScribe reporting link point Cleerly at a coronary CTA program that wants quantified plaque in the report, with six FDA 510(k) clearances behind it. Neither buyer shops for the other product. Hyperfine itself reports preliminary third-quarter 2026 revenue of about $6.0 million against a full-year outlook of $20 million to $22 million.